Neuro-Oncology News

In this episode, Priya U. Kumthekar, MD, discusses her entry into the field of neuro-oncology, her insight into translational medicine and its applications outside of medicine, and more.

The International Society of Magnetic Resonance in Medicine awarded Natalie J. Serkova, PhD, the 2021 Senior Fellow Award for her work in animal imaging for oncology research.

Members of American Society for Radiation Oncology elected three new officers to ASTRO’s board of directors.

The COVID-19 pandemic has underscored the importance of vaccination, both in terms of protecting individuals from infection and eradicating threats to public health.

Young children with brain tumors experienced cognitive difficulties prior to adjuvant treatment, with those of a younger age at diagnosis and lower socioeconomic status at greatest risk, according to a study in Journal of Clinical Oncology.

The FDA granted orphan drug designation to iniparib for treatment of malignant glioma, according to the agent’s manufacturer.

Genetic alterations of ALK, including clonal mutations and amplifications, in high-risk neuroblastoma demonstrated utility as independent predictors of poorer survival, according to a study published in Journal of Clinical Oncology.

Patients with glioma who completed the 8-week GLioma Atkins-based Diet experienced “meaningful” ketonuria and significant systemic and cerebral metabolic changes, according to results from a small study published in Neurology.

The FDA granted fast track designation to berubicin for the treatment of recurrent glioblastoma multiforme, according to the agent’s manufacturer.

A blood-based test demonstrated efficacy and high specificity in detecting multiple cancer types with diverse biological features, paving the way for a new screening option, according to research published in Annals of Oncology.